Phenylketonuriában szenvedő várandós anya vérének emelkedett phenylalanin-koncentrációja a magzatra teratogén hatással van, embryo-foetopathiát okoz. Élveszülés esetén a kórkép jellemzői az intrauterin sorvadás, az általában jelentős fokú pszichomotoros retardáció és a gyakori fejlődési rendellenességek. Az így kialakuló tünetcsoportot maternális phenylketonuria szindrómának nevezzük. Azoknak a fogamzóképes korba került nőknek, akik vérében a phenylalanin-koncentráció a normálisnál magasabb, akár a phenylketonuria bármely formája, akár az egyébként ke zelést nem igénylő enyhe variáns, a hyperphenylalaninaemia esetén, még a gyermek vállalása előtt részletes felvilágosításban kell részesülniük arról a potenciális veszélyforrásról, amit állapotuk/betegségük a magzatra nézve jelenthet. A maternális phenylketonuria megelőzésének legbiztosabb módja, ha a fogamzás előtt és mindvégig a terhesség alatt az anyai vér phenylalanin-koncentrációja a normális tartományban van. A szerzők a Budapesti Anyagcsere Szűrő és Gondozó Központban a megelőzés érdekében tett intézkedéseket, valamint a gondozás gyakorlati kérdéseit ismer tetik, és áttekintik a budapesti központhoz tartozó phenylketonuriás anyák várandósságainak kimenetelét a hazai phenylketonuria-szűrés bevezetésétől napjainkig. Orv. Hetil., 2013, 154, 683–687.
Williams, R. A., Mamotte, C. D., Burnett, J. R.: Phenylketonuria: an inborn error of phenylalanine metabolism. Clin. Biochem. Rev., 2008, 29, 31–41.
Burnett J. R. , 'Phenylketonuria: an inborn error of phenylalanine metabolism ' (2008 ) 29 Clin. Biochem. Rev. : 31 -41 .
Hennermann, J. B., Bührer, C., Blau, N., et al.: Long term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria. Mol. Genet. Metab., 2005, 86 (Suppl. 1), S86–S90.
Blau N. , 'Long term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria ' (2005 ) 86 Mol. Genet. Metab. : S86 -S90 .
Koch, R., Hanley, W., Levy, H. L., et al.: The maternal phenylketonuria international study: 1984–2002. Pediatrics, 2003, 112 (6 Pt 2), 1523–1529.
Levy H. L. , 'The maternal phenylketonuria international study: 1984–2002 ' (2003 ) 112 Pediatrics : 1523 -1529 .
Dyer, C. A.: Pathophysiology of phenylketonuria. Ment. Retard. Dev. Diasab. Res. Rev., 1999, 5, 104–112.
Dyer C. A. , 'Pathophysiology of phenylketonuria ' (1999 ) 5 Ment. Retard. Dev. Diasab. Res. Rev. : 104 -112 .
Walter, J. H., White, F., Wraith, J. E., et al.: Complete reversal of moderate/severe brain MRI abnormalities in a patient with classical phenylketonuria. J. Inherit. Metab. Dis., 1997, 20, 367–369.
Wraith J. E. , 'Complete reversal of moderate/severe brain MRI abnormalities in a patient with classical phenylketonuria ' (1997 ) 20 J. Inherit. Metab. Dis. : 367 -369 .
Scriver, C. R., Kaufman, S., Eisensmith, R. C., et al.: The hyperphenylalaninaemias. In: Scriver, R., Beaudet, A. L., Sly, W. S., et al. (eds.): The metabolic and molecular bases of inherited di sease. 7th ed. Mc-Graw-Hill, New York, NY, 1995, 1015–1075.
Eisensmith R. C. , '', in The metabolic and molecular bases of inherited di sease , (1995 ) -.
dos Santos, L. L., de Castro Magalhães, M., Januário, J., et al.: The time has come: a new scene for PKU treatment. Genet. Mol. Res., 2006, 5, 33–44.
Januário J. , 'The time has come: a new scene for PKU treatment ' (2006 ) 5 Genet. Mol. Res. : 33 -44 .
Rouse, B., Matalon, R., Koch, R., et al.: Maternal phenylketonuria syndrome: congenital heart defects, microcephaly, and developmental outcomes. J. Pediatr., 2000, 136, 57–61.
Koch R. , 'Maternal phenylketonuria syndrome: congenital heart defects, microcephaly, and developmental outcomes ' (2000 ) 136 J. Pediatr. : 57 -61 .
Levy, H. L.: Historical background for the maternal PKU syndrome. Pediatrics, 2003, 112 (6 Pt 2), 1516–1518.
Levy H. L. , 'Historical background for the maternal PKU syndrome ' (2003 ) 112 Pediatrics : 1516 -1518 .
Lipson, A., Beuhler, B., Bartley, J., et al.: Maternal hyperphenyl alaninemia, fetal effects. J. Pediatr., 1984, 104, 216–220.
Bartley J. , 'Maternal hyperphenyl alaninemia, fetal effects ' (1984 ) 104 J. Pediatr. : 216 -220 .
Dent, C. E.: Relation of biochemical abnormality to development of mental defect in phenylketonuria. In: Etiologic Factors in Mental Retardation: Report of the Twenty-third Ross Pediatric Research Conference. Ross Laboratories, Columbus, O. H., 1957, 28–33.
Dent C. E. , '', in Etiologic Factors in Mental Retardation: Report of the Twenty-third Ross Pediatric Research Conference , (1957 ) -.
Mabry, C. C., Denniston, J. C., Nelson, T. L., et al.: Maternal phenylketonuria: a cause of mental retardation in children without the metabolic defect. N. Engl. J. Med., 1963, 269, 1404–1408.
Nelson T. L. , 'Maternal phenylketonuria: a cause of mental retardation in children without the metabolic defect ' (1963 ) 269 N. Engl. J. Med. : 1404 -1408 .
Lenke, R. R., Levy, H. L.: Maternal phenylketonuria and hy perphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N. Engl. J. Med., 1980, 303, 1202–1208.
Levy H. L. , 'Maternal phenylketonuria and hy perphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies ' (1980 ) 303 N. Engl. J. Med. : 1202 -1208 .
Güttler, F., Azen, C., Guldberg, P., et al.: Relationship among genotype, biochemical phenotype, and cognitive performance in females with phenylalanine hydroxylase deficiency: report from the maternal phenylketonuria collaborative study. Pediatrics, 1999, 104 (2 Pt 1), 258–262.
Guldberg P. , 'Relationship among genotype, biochemical phenotype, and cognitive performance in females with phenylalanine hydroxylase deficiency: report from the maternal phenylketonuria collaborative study ' (1999 ) 104 Pediatrics : 258 -262 .
Maillot, F., Lilburn, M., Baudin, J., et al.: Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine. Am. J. Clin. Nutr., 2008, 88, 700–705.
Baudin J. , 'Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine ' (2008 ) 88 Am. J. Clin. Nutr. : 700 -705 .
Waisbren, S. E., Hanley, W., Levy, H. L., et al.: Outcome at age 4 years in offspring of women with maternal phenylketonuria: the Maternal PKU Collaborative Study. JAMA, 2000, 283, 756–762.
Levy H. L. , 'Outcome at age 4 years in offspring of women with maternal phenylketonuria: the Maternal PKU Collaborative Study ' (2000 ) 283 JAMA : 756 -762 .
Lee, P. J., Ridout, D., Walter, J. H., et al.: Maternal phenylketonuria report from the United Kingdom Registry 1978–1997. Arch. Dis. Child., 2005, 90, 143–146.
Walter J. H. , 'Maternal phenylketonuria report from the United Kingdom Registry 1978–1997 ' (2005 ) 90 Arch. Dis. Child. : 143 -146 .
Brown, A. S., Fernhoff, P. M., Waisbren, D. M., et al.: Barriers to successful dietary control among pregnant women with phenylketonuria. Genet. Med., 2002, 4, 84–89.
Waisbren D. M. , 'Barriers to successful dietary control among pregnant women with phenylketonuria ' (2002 ) 4 Genet. Med. : 84 -89 .
Brenton, D. P., Lilburn, M.: Maternal phenylketonuria. A study from the United Kingdom. Eur. J. Pediatr., 1996, 155 (Suppl. 1), S177–S180.
Lilburn M. , 'Maternal phenylketonuria. A study from the United Kingdom ' (1996 ) 155 Eur. J. Pediatr. : S177 -S180 .
Matalon, K. M., Acosta, P. B., Azen, C.: Role of nutrition in pregnancy with phenylketonuria and birth defects. Pediatrics, 2003, 112, 1534–1536.
Azen C. , 'Role of nutrition in pregnancy with phenylketonuria and birth defects ' (2003 ) 112 Pediatrics : 1534 -1536 .
Schwoerer, J. A., Obernolte, L., Van Calcar, S., et al.: Use of gastrostomy tube to prevent maternal PKU syndrome. JIMD Rep., 2012, 6, 15–20.
Calcar S. , 'Use of gastrostomy tube to prevent maternal PKU syndrome ' (2012 ) 6 JIMD Rep. : 15 -20 .
Somogyi, Cs., Kiss, E., Kásáné Soltysiak, J.: Maternal PKU syndrome. [Az anyai PKU szindrómáról.] Magyarországi PKU Egyesület, Budapest, 2000, 1–31. [Hungarian]
Kásáné Soltysiak J. , '', in Maternal PKU syndrome. [Az anyai PKU szindrómáról.] , (2000 ) -.
Trefz, F. K., Funk-Wentzel, P., Heinemann, J.: Maternale PKU. In: Erfahrungen und Behandlungsstrategien. SPS Verlagsgesellschaft, Heilbronn, 2005.
Heinemann J. , '', in Erfahrungen und Behandlungsstrategien , (2005 ) -.
Hennermann, J. B., Bührer, C., Blau, N., et al.: Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria. Mol. Genet. Metab., 2005, 86 (Suppl. 1), S86–S90.
Blau N. , 'Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria ' (2005 ) 86 Mol. Genet. Metab. : S86 -S90 .
Koch, R., Moseley, K., Guttler, F.: Tetrahydrobiopterin and PKU. Mol. Genet. Metab., 2005, 86 (Suppl. 1), S139–S141.
Guttler F. , 'Tetrahydrobiopterin and PKU ' (2005 ) 86 Mol. Genet. Metab. : S139 -S141 .
Koch, R., Mosely, K.: Maternal phenylketonuria and tetrahydro biopterin. Pediatrics, 2008, 122, 1367–1368.
Mosely K. , 'Maternal phenylketonuria and tetrahydro biopterin ' (2008 ) 122 Pediatrics : 1367 -1368 .
Moseley, K., Skrabal, J., Yano, S., et al.: Sapropterin dihydrochloride (6R-BH4) and maternal phenylketonuria two case studies. ICAN, 2009, 1, 262–266.
Yano S. , 'Sapropterin dihydrochloride (6R-BH4) and maternal phenylketonuria two case studies ' (2009 ) 1 ICAN : 262 -266 .
Trefz, F. K., Blau, N.: Potential role of tetrahydrobiopterine in the treatment of maternal phenylketonuria. Pediatrics, 2003, 112 (6 Pt 2), 1566–1569.
Blau N. , 'Potential role of tetrahydrobiopterine in the treatment of maternal phenylketonuria ' (2003 ) 112 Pediatrics : 1566 -1569 .